Semaglutide and Vitamin B12: What You Should Know

What the clinical data says about GLP-1 medicines and B12

The STEP 1 trial (the pivotal 68-week study of semaglutide 2.4mg published in the New England Journal of Medicine) documented meaningful average weight loss but did not flag B12 deficiency as a significant treatment-emergent event in the trial population. That matters, but it doesn't settle the question for every individual. Trial participants had structured dietary support throughout, which means intake of nutrients including B12 was more monitored than it typically is in real-world use.

Semaglutide's mechanism slows gastric emptying and reduces appetite through GLP-1 receptor activation, and if you're curious about what that can look like over time, our semaglutide transformations page shows how results vary across different people and starting points. A smaller diet doesn't automatically mean a nutritionally poor one, but it does mean the margin for error shrinks. Someone already eating little red meat, few eggs and minimal dairy before starting treatment has less buffer than someone whose diet was varied and plentiful.

Vitamin B12 and Wegovy isn't a pairing the prescribing literature flags as a pharmacokinetic interaction, B12 absorption depends on intrinsic factor produced in the stomach, and semaglutide doesn't suppress that. What it does do is reduce the volume of B12-containing food passing through, and in some people, persistent nausea during dose titration further narrows food choices. Those two factors combined can quietly reduce intake over months.

Our prescribers hear this question most weeks, particularly from patients who've been on treatment for three months or more and have started feeling more tired than expected. Fatigue is a recognised side effect early in treatment, but if it persists well past the initial titration period it's worth asking your GP to check your B12 alongside other markers. The NHS semaglutide patient information recommends telling your doctor about any new or persistent symptoms.

Which people are most likely to notice a B12 shortfall on semaglutide

B12 deficiency before starting treatment is more common than many people realise. Older adults absorb it less efficiently. People following a vegan or largely plant-based diet get almost none from food unless they supplement deliberately. Those with a history of gut surgery, autoimmune gastritis or coeliac disease may have impaired intrinsic factor production regardless of what they eat. If any of these apply, the additional reduction in dietary intake that comes with semaglutide treatment creates a meaningful cumulative risk.

It also matters which form of semaglutide you're taking. The injectable route (Wegovy) involves a slow titration from 0.25mg upward, typically over several months. During that period nausea is most pronounced, and food aversions are common. Some people find they gravitate to plain carbohydrates because they're easier to tolerate, unintentionally reducing protein and B12 intake at the same time. If you're exploring what vitamins to think about alongside treatment, our page on vitamins to take when on Wegovy covers the broader picture.

People who have previously taken metformin for type 2 diabetes are a specific group worth mentioning. Metformin actively interferes with B12 absorption through a different mechanism (it reduces uptake in the gut) so anyone moving from a metformin-containing regimen to or alongside a GLP-1 medicine may carry pre-existing lower B12 stores into treatment. That's a conversation worth having with your prescriber before starting.

Practical steps: monitoring, diet and supplementation

There's no universal recommendation to supplement B12 simply because you're taking semaglutide. The evidence doesn't support blanket supplementation the way it does for, say, vitamin D in the UK winter, and our dedicated page on vitamin D and Wegovy explains how that particular nutrient sits differently in the picture. What it does support is awareness and, where risk factors are present, baseline blood testing before or soon after starting treatment. A full blood count and B12 level is a straightforward request at your GP surgery.

If your levels are within the normal range and your diet includes a reasonable variety of animal proteins, monitoring periodically (perhaps at six months and a year) is a sensible approach. If levels are borderline or low, supplementation is effective and inexpensive; B12 is one of the few vitamins where taking more than you need carries very little risk, as excess is excreted. The form matters slightly: cyanocobalamin and methylcobalamin are both available over the counter, and either is appropriate for most people. Injected B12 (hydroxocobalamin) is used for severe deficiency or absorption problems and is a GP-administered treatment.

Diet-wise, prioritising protein-rich foods during treatment helps on multiple fronts. Preserving muscle mass alongside fat loss is one goal; adequate B12 intake is another. Eggs, fish, chicken, dairy and fortified foods all contribute. If nausea is making those foods unappealing, that's worth raising with your prescriber, adjusting the titration pace can make a real difference to tolerability and therefore to what you're actually able to eat. For a fuller look at how B12 and Wegovy interact in practice, see our dedicated page on B12 and Wegovy.

If you're considering semaglutide for weight management and want a clinical assessment that takes your full health picture into account, start your free consultation with our prescribers.